Ovarian cancer research has received a boost today, with the Ovarian Cancer Research Foundation and Cancer Council Victoria committing $300,000 to jointly-fund a project as part of Cancer Council’s Grant-in-Aid program.
Ovarian cancer is the eighth most common cancer in women in Australia, with about 1,400 women diagnosed each year.
Lucinda Nolan, CEO of the Ovarian Cancer Research Foundation (OCRF), said funding into ovarian cancer research is vital, especially as there is currently no early detection test for the disease.
“Ovarian cancer is known as the silent killer due to the fact the symptoms associated with the disease are vague and easily mistaken for common women’s health issues.
“The majority of women (70%) are diagnosed with advanced stage ovarian cancer because there is no early detection test. Less than 25% of these women will survive beyond 5 years,” Ms Nolan said.
Danielle Spence, Head of Strategy & Support at Cancer Council Victoria, said the organisation was proud to be partnering with OCRF to provide this opportunity for world-leading researchers in Victoria to conduct research into ovarian cancer.
“Cancer Council has long advocated for increased research funding into cancer with low survival – cancers with less than a 50% five-year survival rate.”
“We are delighted to fund research to build on the body of evidence needed to improve these survival rates. By committing $150,000 to this grant, jointly with the OCRF, we will be funding world-class ovarian cancer research, that can one day deliver real outcomes for women and their families.”
The research project grant will run from 2020-2022.